Literature DB >> 3791223

The appropriate breast cancer paradigm.

S Hellman, J R Harris.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3791223

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

1.  Controversies in the Surgical Management of Operable Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

2.  [Not Available].

Authors:  David Krug
Journal:  Strahlenther Onkol       Date:  2014-10       Impact factor: 3.621

Review 3.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. A review.

Authors:  A Recht; M J Houlihan
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

Review 5.  [Magnetic resonance imaging in preoperative staging for breast cancer: pros and contras].

Authors:  C K Kuhl; M Braun
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

6.  Integrated landscape of copy number variation and RNA expression associated with nodal metastasis in invasive ductal breast carcinoma.

Authors:  Michael Behring; Sadeep Shrestha; Upender Manne; Xiangqin Cui; Agustin Gonzalez-Reymundez; Alexander Grueneberg; Ana I Vazquez
Journal:  Oncotarget       Date:  2018-12-07

7.  The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer.

Authors:  T Kato; S Kameoka; T Kimura; T Nishikawa; M Kobayashi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

8.  Impact of molecular weight on lymphatic drainage of a biopolymer-based imaging agent.

Authors:  Taryn R Bagby; Shuang Cai; Shaofeng Duan; Sharadvi Thati; Daniel J Aires; Laird Forrest
Journal:  Pharmaceutics       Date:  2012-05-23       Impact factor: 6.321

Review 9.  Clinical utility of aromatase inhibitors as adjuvant treatment in postmenopausal early breast cancer.

Authors:  Arturo Loaiza-Bonilla; Francisco Socola; Stefan Glück
Journal:  Clin Med Insights Womens Health       Date:  2013-01-22

10.  The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study.

Authors:  Mahvish Muzaffar; Helen M Johnson; Nasreen A Vohra; Darla Liles; Jan H Wong
Journal:  Int J Breast Cancer       Date:  2018-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.